🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT06537622
Starting soon Not applicable

Best Practices Fo Early Diagnosis of Cerebral Palsy

NCT06537622 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2025-02-01
Last updated
2024-12-18

Condition(s) studied

Cerebral PalsyPrematurity

Investigational drug(s) / intervention(s)

Implementation groupStandard of care

Implementation group: Implementation strategies to increase uptake of the clinical practice guidelines for earlier diagnosis of cerebral palsy

Standard of care: No active implementation strategies

Study summary

In this research, the investigators are using an implementation science approach to enhance the uptake of a clinical practice guideline for earlier diagnosis of cerebral palsy (i.e. what is being implemented) in neonatal follow-up clinics across Canada. This clinical practice guideline should be part of what neonatal follow-up specialists do in their routine clinical work with children born preterm. However, there is a wide variability in practice. The goal of this project is to harmonize practices in the neonatal follow-up community in agreement with international recommendations for earlier diagnosis of cerebral palsy. This research will measure if clinicians are truly following the clinical practice guideline. If not, implementation strategies that address barriers and leverage on facilitators will be deployed for successful uptake of the clinical practice guideline. This research will also assess whether implementation of the clinical practice guideline is associated with better patient outcomes.

Eligibility

Sex
ALL
Min age
2 Months
Max age
30 Months
Healthy volunteers
Accepted
Inclusion Criteria: * Infants born preterm at less than 29 weeks' GA and their parents * Admission to a Neonatal Intensive Care Unit (NICU) participating in the Canadian Neonatal Network (CNN). Exclusion Criteria: * Death prior to first visit in clinic * Major congenital malformation and/or significant chromosomal defects affecting development beyond preterm birth * Child moved outside Canada prior to first visit in clinic.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
CHU Sainte-Justine Montreal Quebec

More St. Justine's Hospital trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06537622 on ClinicalTrials.gov ↗ ← All trials in Canada